| Term es nes pval sidak fdr geneset_size leading_edge leading_edge_size |
| Cytoplasmic ribosomal proteins 0.5600133793083423 3.551933921606402 0.0003824108818526 0.2059730401042513 0.2305937617571462 72 P62266,P61513,P61353,Q02878,P26373,P46778,P18077,P62263,P62910,P46779,P62829,P42766,P27635,P49207,P46777,P62917,P61254,P23396,P47914,P62753,P62424,P39023,P40429,P61247,P84098,P35268,P62280,P50914,Q9Y3U8,Q02543 30 |
| Cholesterol biosynthesis with skeletal dysplasias 0.8574950814379567 2.548895399395456 0.0108064707312434 0.9985724087490108 0.965710514377473 6 Q15392,Q16850,Q9UBM7,Q14739 4 |
| Cholesterol metabolism with bloch and kandutschrussell pathways 0.5728207994333554 2.468627220369169 0.0135632430265941 0.9997346886806848 0.965710514377473 23 Q15392,P14324,Q9UBM7,Q9BWD1,O60488,Q14739,Q16850 7 |
| Nsp1 from sarscov2 inhibits translation initiation in the host cell 0.7071033392688708 2.2080067425939447 0.0272438031474131 0.999999941599618 0.965710514377473 13 P20042,O75822,Q13347 3 |
| Translation factors 0.4391433868200566 1.9804717194237131 0.0476505480722546 0.9999999999998362 1.0 36 O15372,Q9NR50,O75822,O75153,Q13144,P20042,Q13347 7 |
| Fbxl10 enhancement of maperk signaling in diffuse large bcell lymphoma 0.7198417844851899 1.9586089310311183 0.0501586028652991 0.9999999999999666 1.0 7 Q9P0M6,P84243 2 |
| Oxidation by cytochrome p450 0.6955701119443438 1.810439753371349 0.0702276192043223 1.0 1.0 6 Q9UHQ9,Q16850 2 |
| Type 2 papillary renal cell carcinoma 0.6802109809424062 1.7679780463785988 0.0770645738668678 1.0 1.0 7 Q15369,Q92733,P23246 3 |
| Striated muscle contraction pathway 0.7830045523520462 1.7376300910042837 0.082276014143257 1.0 1.0 4 P67936,O43707,P08670 3 |
| Mechanoregulation and pathology of yaptaz via hippo and nonhippo mechanisms 0.6741573033707942 1.708549065347325 0.0875345103950877 1.0 1.0 6 P35240,P05556,P35222,P35221,P27348 5 |
| Nonalcoholic fatty liver disease 0.3609461755908216 1.6502917459810305 0.0988832796665357 1.0 1.0 48 P20674,O43678,P09669,P49841,P13073,P22695,P15954,Q9UDW1,P31040,O75251,P08574,P49840 12 |
| Tca cycle aka krebs or citric acid cycle 0.5669526926370466 1.622854577765089 0.1046204954089451 1.0 1.0 16 Q96I99,P09622,P40926,P51553,Q9P2R7,P50213,P53597,P31040,P36957 9 |
| Tca cycle and deficiency of pyruvate dehydrogenase complex pdhc 0.5689779166031153 1.5629476867340422 0.1180648999373197 1.0 1.0 15 Q96I99,P40925,P09622,P50213,P31040,P08559,P36957,P10515 8 |
| Kennedy pathway from sphingolipids 0.6802166752338543 1.5609633161119183 0.1185324065368458 1.0 1.0 5 P35790 1 |
| Mitochondrial complex iv assembly 0.6129807867643112 1.5395278764754337 0.1236754777707171 1.0 1.0 10 P20674,P09669,P13073,O00483,P15954,Q9Y241,O43819 7 |
| Krebs cycle disorders 0.6363620848525365 1.5267246298236503 0.1268295002020671 1.0 1.0 6 Q96I99,P53597,P36957,Q9P2R7 4 |
| Sudden infant death syndrome sids susceptibility pathways 0.4123101020859364 1.5134379721074644 0.1301684457721412 1.0 1.0 27 P63104,P04406,P14625,P04075,P40939,P61981,P62258,Q9H0U9,P35222,Q04917,P27348 11 |
| Wntbetacatenin signaling pathway in leukemia 0.7203036951379311 1.4674043129674814 0.1422661019275355 1.0 1.0 4 P49841 1 |
| Neural crest differentiation 0.6043827052164116 1.4563035380425513 0.1453087279157294 1.0 1.0 9 P49841,P56545,Q9NR77,P35222 4 |
| Interactome of polycomb repressive complex 2 prc2 0.6204915722425799 1.4497418236164872 0.1471305280549089 1.0 1.0 6 Q9NYF8 1 |
| Acquired partial lipodystrophy barraquersimons syndrome 0.7135406119872891 1.4380442892940704 0.1504214881056389 1.0 1.0 4 P20700,P02545 2 |
| Mevalonate pathway 0.650490207429275 1.4237699778148278 0.1545130691124194 1.0 1.0 5 Q9BWD1 1 |
| Preimplantation embryo 0.6091924452754163 1.419066862801308 0.1558795236861425 1.0 1.0 7 Q92945 1 |
| Pregnane x receptor pathway 0.6474399221931183 1.4096440168274766 0.1586448229352794 1.0 1.0 5 Q99615,P08183 2 |
| Acetylcholine synthesis 0.8837985436893236 1.3865804333691365 0.165569738155467 1.0 1.0 3 P35790,P08559 2 |
| Leukocyteintrinsic hippo pathway functions 0.7010319020738423 1.3836723049928454 0.1664588174487491 1.0 1.0 4 P51153 1 |
| Il7 signaling pathway 0.6007655994477012 1.3536656199061126 0.1758430813661484 1.0 1.0 6 P49841,Q02750 2 |
| Ccl18 signaling pathway 0.5837915825057108 1.3496317438196597 0.1771341365425371 1.0 1.0 9 P27144,Q86UE4 2 |
| Sleep regulation 0.6925644916540163 1.346828465861816 0.1780354845402048 1.0 1.0 4 Q99808,P00813,P10515 3 |
| Endometrial cancer 0.5663391326818417 1.331342850614918 0.1830762246405444 1.0 1.0 11 P04637,Q02750,P49841,P35222,Q13418,P27361 6 |
| Electron transport chain oxphos system in mitochondria 0.3431731990636421 1.3107336008112018 0.1899477824214681 1.0 1.0 45 P20674,O43678,O75880,P09669,P13073,P22695,P15954,P24539,P31040,Q9UDW1,O75251 11 |
| Regulation of apoptosis by parathyroid hormonerelated protein 0.6836682809715671 1.3080983162524669 0.1908399644904599 1.0 1.0 4 P49840 1 |
| Mitochondrial complex iii assembly 0.5737969245274419 1.29772478980006 0.1943819220064591 1.0 1.0 9 Q6DKK2,Q9UDW1 2 |
| Overlap between signal transduction pathways contributing to lmna laminopathies 0.5115001943661466 1.215889772635841 0.2240269145863958 1.0 1.0 15 O75844,P42167,P50402,P02545,P49841,P35222 6 |
| Ncrnas involved in wnt signaling in hepatocellular carcinoma 0.5527038733236488 1.1880588511802814 0.234810224509915 1.0 1.0 9 P67870,P49841,P56545,Q86UE4 4 |
| T cell receptor and costimulatory signaling 0.5578434089310158 1.1633292654002647 0.2446959362830805 1.0 1.0 7 P49840,P49841,Q08209 3 |
| Tgfbeta receptor signaling 0.6501954716990881 1.1624180890938698 0.2450656790258796 1.0 1.0 4 P35222 1 |
| Tgfbeta receptor signaling in skeletal dysplasias 0.6501954716990881 1.1624180890938698 0.2450656790258796 1.0 1.0 4 P35222 1 |
| Circadian rhythm genes 0.3205368908406845 1.0960285298522188 0.2730662893733471 1.0 1.0 46 Q9BWF3,Q96ST3,Q03164,P49841,O75116,P00813,Q15233,O14744,Q9Y2W1,Q05086,P17844,Q8N163,P23246 13 |
| Histone modifications 0.5329782125333493 1.0855914106434554 0.2776598015889258 1.0 1.0 9 Q03164,P84243 2 |
| Ketogenesis and ketolysis 0.5740300246404096 1.0689110884536694 0.2851097349903018 1.0 1.0 5 O43772,P24752,P53985 3 |
| Influence of laminopathies on wnt signaling 0.5218945952205458 1.056421759773687 0.2907755689542202 1.0 1.0 10 O75844,P50402,P02545,P49841,P35222 5 |
| Il5 signaling pathway 0.5072983199492984 1.046476204246367 0.2953412257137482 1.0 1.0 12 P62753,P49841,Q02750,P49840 4 |
| Prion disease pathway 0.5343045539377859 1.0461658193391616 0.2954844809604777 1.0 1.0 7 P30101,Q9UQE7,P14625 3 |
| Alanine and aspartate metabolism 0.6203338391502162 1.033051780241076 0.3015796673375703 1.0 1.0 4 P14868,P00505,P11498 3 |
| Tryptophan metabolism 0.4888945445744073 1.0279312709316366 0.3039821586155076 1.0 1.0 14 Q15392,P40939 2 |
| Metabolic reprogramming in colon cancer 0.3396310576810881 0.998800764699917 0.3178912155255915 1.0 1.0 36 P00367,P04406,P40926,P50213,Q9Y617,P08559,Q06203,P29401,P00505,P36957,P18669 11 |
| Hair follicle development organogenesis part 2 of 3 0.7824635922330094 0.9967388663308696 0.3188912789686113 1.0 1.0 3 P35222,Q9BZE4 2 |
| Aryl hydrocarbon receptor pathway wp2873 0.6108822164773722 0.9923507349262938 0.3210264621595313 1.0 1.0 4 P07900 1 |
| Amyotrophic lateral sclerosis als 0.5068310319160045 0.9504775037980544 0.3418696793206477 1.0 1.0 9 Q9UER7,Q08209 2 |
| Hijack of ubiquitination by sarscov2 0.5130249175658552 0.9258714597855862 0.354512784851595 1.0 1.0 6 Q15369 1 |
| Regulation of wnt bcatenin signaling by small molecule compounds 0.7609112054672615 0.9156467618871986 0.3598521965088486 1.0 1.0 3 P49841 1 |
| Mitochondrial gene expression 0.5107591655934873 0.914945472263558 0.3602202565619405 1.0 1.0 6 O00411,Q08209 2 |
| Prolactin signaling pathway 0.4220155703571276 0.903357380375854 0.3663362519154547 1.0 1.0 19 P63104,P62753,Q02750,P23284,P49841,P21333,P61981,P05556 8 |
| Effect of progerin on genes involved in hutchinsongilford progeria syndrome 0.4674165903570765 0.9027786924576364 0.3666433619298554 1.0 1.0 14 P45973,Q14839,O94776,P83916,P84243,Q16576 6 |
| Metapathway biotransformation phase i and ii 0.4098252360029638 0.8945949613115006 0.3710036463146315 1.0 1.0 20 P78417,P07099,O14880,Q9H0A0,P48637,P00390,Q99735,Q16850 8 |
| Myometrial relaxation and contraction pathways 0.4130502852957691 0.8426780686036794 0.3994085160687013 1.0 1.0 19 P63104,Q05682,P10644,P61981,P62258,Q04917,P19174,P27348 8 |
| Glycolysis and gluconeogenesis 0.3390911547072898 0.8418465590019997 0.399873846883513 1.0 1.0 26 P04406,P04075,P40925,P00505,P08559,P10515,P18669 7 |
| Glucocorticoid receptor pathway 0.495312316270572 0.8408508017040199 0.4004315230156283 1.0 1.0 6 P27105,Q86UP2,P07900 3 |
| Cholesterol biosynthesis pathway 0.4573890116788297 0.8060147288434965 0.4202343565236566 1.0 1.0 13 P14324,Q9UBM7,Q16850 3 |
| Vitamin a and carotenoid metabolism 0.5550834597875614 0.7566319233517207 0.449270410299863 1.0 1.0 4 P28482,Q6NUM9,P29375 3 |
| Development of ureteric collection system 0.5030932094875132 0.7461675583626748 0.4555662027805578 1.0 1.0 5 P35222,Q13418 2 |
| Mrna processing 0.3449834573512036 0.7293184908844645 0.4658068639420665 1.0 1.0 101 Q7RTV0,Q96I25,Q15366,P35637,Q14103,P55769,P23246,P22626,Q15233,O94906,Q15428,Q15427,Q92499,Q00839,Q8IWZ8,Q05048,O75937,Q13523,Q13247,P24928,Q16629,Q9UK45,Q86U42,P84103,P08621,P52756,Q08170,Q8IX01,P14866,Q01081,O43395,O75400,Q13435 33 |
| Copper homeostasis 0.464564824706636 0.7194220535647584 0.4718809126630687 1.0 1.0 8 P49841,O43819,P05067 3 |
| Photodynamic therapyinduced nfe2l2 nrf2 survival signaling 0.4695657952454892 0.7193779751484356 0.4719080635766128 1.0 1.0 6 P07099 1 |
| Exerciseinduced circadian regulation 0.4348716473081773 0.7168972965112995 0.4734374702391632 1.0 1.0 14 Q96KR1,Q9P0L0 2 |
| Type i collagen synthesis in the context of osteogenesis imperfecta 0.4461184098182356 0.7123735355561227 0.4762334988548018 1.0 1.0 12 O15460,P23284,Q32P28,Q5JRA6,P13674 5 |
| Intraflagellar transport proteins binding to dynein 0.4572339986125457 0.6999598097721282 0.483952403912673 1.0 1.0 9 P63167 1 |
| Regulation of sister chromatid separation at the metaphaseanaphase transition 0.4624074206533732 0.695953932446295 0.4864576801971223 1.0 1.0 7 O43684,O43683 2 |
| Nad metabolism sirtuins and aging 0.5378907414751999 0.6863826640573568 0.4924718335299349 1.0 1.0 4 Q00059 1 |
| Constitutive androstane receptor pathway 0.4883213258074663 0.6813147095520229 0.4956723777048073 1.0 1.0 5 Q99615,P08183 2 |
| Androgen receptor signaling pathway 0.3134031930288963 0.6809196202280761 0.4959223525325154 1.0 1.0 32 O75925,Q9UER7,Q96ST3,P49841,O75116,P21333,P62826,P35222,Q05086,Q02790,O75928,Q99497 12 |
| Proximal tubule transport 0.4484318671560936 0.6753034169673856 0.4994830134579111 1.0 1.0 10 P04920,P08183 2 |
| Fatty acid betaoxidation 0.3738611919329468 0.6463495435282646 0.518053009179527 1.0 1.0 20 O43772,P40939,O60488 3 |
| Pi3kaktmtor vitd3 signaling 0.4800292536949539 0.6454603792196834 0.5186288861592869 1.0 1.0 5 P08559 1 |
| Hedgehog signaling pathway wp47 0.8431907794965152 0.6423211038373945 0.5206647144667536 1.0 1.0 2 O00422 1 |
| 7q1123 copy number variation syndrome 0.2783793898686862 0.6353549917520124 0.5251969154379355 1.0 1.0 46 Q15056,P04406,P09622,O60264,O60885,P78347,P35659,P16104,P48047,Q9NY93,P35222,Q9UIG0,P24539,P27361,P36957,O75533 16 |
| Amino acid metabolism 0.2743223858456164 0.6290065672610055 0.529344756781301 1.0 1.0 56 P07814,P00367,O15460,Q05682,P40925,P40939,P53597,P48637,P31040,P26640,P48507,P11766,P08559,P00505,P36957 15 |
| Parkinsons disease pathway 0.4320047607233654 0.5779599455072119 0.5632911619858292 1.0 1.0 9 P07814,Q99700,Q99497 3 |
| Mammary gland development pathway pregnancy and lactation stage 3 of 4 0.5098464845800474 0.5754178075132874 0.5650087635776588 1.0 1.0 4 P06730,P06753 2 |
| Aerobic glycolysis 0.4275307782620321 0.5723935545423566 0.5670553814977337 1.0 1.0 10 P00338,P06744,P04075,P04406,P06733,P19367,P14618 7 |
| Intracellular trafficking proteins involved in cmt neuropathy 0.4235183394437827 0.571696236505441 0.567527784553624 1.0 1.0 11 Q8TB36,Q9NR77 2 |
| Proteasome degradation 0.2854565943536149 0.5582290566939596 0.5766879817539419 1.0 1.0 40 P04843,P28074,P25786,P16104,P13747,P28070,P49721 7 |
| Sphingolipid metabolism integrated pathway 0.4199945660623025 0.5362652669165958 0.5917752317617719 1.0 1.0 10 Q96G23,O15121,P27544 3 |
| Sphingolipid metabolism overview 0.4199945660623025 0.5362652669165958 0.5917752317617719 1.0 1.0 10 Q96G23,O15121,P27544 3 |
| Il9 signaling pathway 0.4251560939946711 0.5252252408382345 0.5994266203046386 1.0 1.0 7 Q02750,P27361 2 |
| Oxysterols derived from cholesterol 0.4196992969904866 0.5204653909252067 0.6027392438459558 1.0 1.0 9 Q9UBM7 1 |
| Nad metabolism in oncogeneinduced senescence and mitochondrial dysfunctionassociated senescence 0.4006950561043287 0.5030855954093132 0.6149040937111563 1.0 1.0 13 P40925,P40926,Q15717,P09874,O43819,P00505 6 |
| Nanoparticlemediated activation of receptor signaling 0.4202639933234537 0.4982945508289177 0.6182764480554441 1.0 1.0 6 Q9Y490,Q02750,P05556 3 |
| Burn wound healing 0.4152773785258661 0.4896396227677254 0.6243889331918484 1.0 1.0 8 P04637,O60885,P09429,P08670 4 |
| Chromosomal and microsatellite instability in colorectal cancer 0.3807390013383564 0.4890545402704603 0.6248030844279318 1.0 1.0 16 P04637,P63000,Q02750,P49841,P35222,P27361,P20585 7 |
| Physicochemical features and toxicityassociated pathways 0.3877804084543497 0.4635345966181138 0.6429812223668665 1.0 1.0 14 Q02750,P49841,O75116,P19174,P07197 5 |
| Mfap5mediated ovarian cancer cell motility and invasiveness 0.6265169902912677 0.4510363957538551 0.6519633177179216 1.0 1.0 3 P19174,P27361 2 |
| Serotonin receptor 467 and nr3c signaling 0.6265169902912671 0.4510363957538533 0.6519633177179229 1.0 1.0 3 Q02750,P27361 2 |
| Serotonin receptor 2 and elksrfgata4 signaling 0.6265169902912671 0.4510363957538533 0.6519633177179229 1.0 1.0 3 Q02750,P27361 2 |
| Bile acids synthesis and enterohepatic circulation 0.626516990291256 0.45103639575382 0.6519633177179469 1.0 1.0 3 P51114,P27361 2 |
| Tumor suppressor activity of smarcb1 0.3934166296282058 0.4453005662168199 0.6561025587397136 1.0 1.0 12 Q96GM5,P84243 2 |
| Leptin signaling pathway 0.2898977240079964 0.4297835153225979 0.6673531253624345 1.0 1.0 26 P62753,Q07666,P49841,O75116,P19174,P49840 6 |
| Envelope proteins and their potential roles in edmd physiopathology 0.3629920056707577 0.4283646373270995 0.6683856663192635 1.0 1.0 17 Q14739,P42167,P50402,O94901 4 |
| Familial partial lipodystrophy fpld 0.4024332364173134 0.4275027701458752 0.6690131678882385 1.0 1.0 7 P20700,O75844,P02545 3 |
| Sphingolipid pathway 0.3925381316929032 0.4238955688092559 0.6716419759385888 1.0 1.0 11 Q96G23,Q9Y5P4 2 |
| Hippoyap signaling pathway 0.7661510464058325 0.4226252451757539 0.6725687046611963 1.0 1.0 2 P27348 1 |
| Lncrna in canonical wnt signaling and colorectal cancer 0.3821605291447361 0.4118179717031081 0.6804728477989732 1.0 1.0 13 P67870,Q00839,P49841,P56545,Q9P0M6 5 |
| Mirna regulation of prostate cancer signaling pathways 0.3967167236847841 0.4094216883146626 0.6822302260615902 1.0 1.0 8 P49841,Q02750,P35222 3 |
| Mevalonate arm of cholesterol biosynthesis pathway 0.3918870312625615 0.4073232895425375 0.683770559658055 1.0 1.0 10 Q9BWD1 1 |
| Mfap5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement 0.3939854001940137 0.389944225232077 0.6965777903281307 1.0 1.0 6 P19174,P18206 2 |
| Gpr40 pathway 0.7494692144373691 0.3802119260499081 0.7037881071359722 1.0 1.0 2 P19174 1 |
| Progeriaassociated lipodystrophy 0.384874347099678 0.3673677345962336 0.7133447356356402 1.0 1.0 9 P20700,O75844,P09874,P02545 4 |
| Mapk pathway in congenital thyroid cancer 0.7409766454352462 0.359445491189044 0.7192618483851112 1.0 1.0 2 Q02750 1 |
| Fgfr3 signaling in chondrocyte proliferation and terminal differentiation 0.3859583561949664 0.3586007841085031 0.7198937601246627 1.0 1.0 6 P09543,Q02750,P27361 3 |
| Photodynamic therapyinduced hif1 survival signaling 0.3840068905777796 0.3571494038694652 0.7209799611081338 1.0 1.0 8 P08559,P53985,P19367 3 |
| Nanomaterial induced apoptosis 0.3852632848179787 0.3559296352060189 0.7218932615325171 1.0 1.0 6 Q9NR28 1 |
| 16p112 distal deletion syndrome 0.3814415687431849 0.3531967350539445 0.7239409554082181 1.0 1.0 9 Q8WWM7 1 |
| Allograft rejection 0.3773746675183671 0.3450706094512025 0.7300412881963241 1.0 1.0 10 P13747,Q9BY49,P08183 3 |
| Nucleotide excision repair in xeroderma pigmentosum 0.2658381570829019 0.3389428446602275 0.7346527874144753 1.0 1.0 37 P41440,P18887,P15927,Q9NRF9,P84243 5 |
| Cell cycle 0.237038518412 0.3357409077945077 0.7370662546373872 1.0 1.0 50 Q9UQE7,P63104,P33992,P49841,P06493,P61981,P62258,O43683,Q9UM13,Q04917,O43684,P27348 12 |
| Primary focal segmental glomerulosclerosis fsgs 0.3303631167677978 0.3265553817688806 0.7440041950329577 1.0 1.0 19 O43707,P05556,P35222,Q13418,P19174,P27348,P18206,P08670 8 |
| Complement system in neuronal development and plasticity 0.3652715595180938 0.3176959405740568 0.7507155907681722 1.0 1.0 12 Q7KZI7,Q9NR28,Q8NB49 3 |
| Sarscov2 b117 variant antagonises innate immune activation 0.7197452229299459 0.3101158516051785 0.7564728582710869 1.0 1.0 2 O94826 1 |
| Vasopressinregulated water reabsorption 0.3404493693821253 0.3100880868668493 0.7564939713740622 1.0 1.0 17 P63167,Q96FJ2 2 |
| Nrp1triggered signaling pathways in pancreatic cancer 0.3684031177617548 0.3083286225971211 0.7578322885660747 1.0 1.0 10 O14646,Q02750,P49840,P27361 4 |
| Sterol regulatory elementbinding proteins srebp signaling 0.2668906042033737 0.3041084429566517 0.7610452747366843 1.0 1.0 33 Q15437,P40925,P14324,P48449,P49840,Q16850 6 |
| Mitochondrial long chain fatty acid betaoxidation 0.3533238482785013 0.298357258016105 0.7654305074263312 1.0 1.0 14 O43772,P40939 2 |
| Tca cycle nutrient use and invasiveness of ovarian cancer 0.5708148738038017 0.2951968568092467 0.7678435029720028 1.0 1.0 3 P27361 1 |
| Omega9 fatty acid synthesis 0.3683161364222968 0.2930761773444853 0.7694639253953748 1.0 1.0 6 O00767,O95864,O60488 3 |
| 3q29 copy number variation syndrome 0.350582647454591 0.2862181939901906 0.7747110096007195 1.0 1.0 14 P63167,Q96FJ2 2 |
| Nipbl role in dna damage cornelia de lange syndrome 0.3863925792105579 0.2843743894948261 0.7761234833900925 1.0 1.0 5 Q14676 1 |
| Onecarbon metabolism and related pathways 0.3489875109244452 0.2792310683026234 0.7800675024161816 1.0 1.0 14 P49585,O43865,P35790,P48637 4 |
| Cellular proteostasis 0.4209408194233839 0.2703046355187367 0.786925899426953 1.0 1.0 4 Q99471,P61758,O15212 3 |
| Endoderm differentiation 0.2644076322088128 0.2702489252664808 0.7869687555303084 1.0 1.0 31 O75925,P05067,Q8IWS0,P56545,O75717,P15531,Q6PD62 7 |
| Urea cycle and associated pathways 0.3503188150008925 0.2687209225135402 0.7881444499722574 1.0 1.0 13 P00505,P00367,P40925 3 |
| Tca cycle in senescence 0.3605044474015857 0.2672297807569044 0.7892922479134097 1.0 1.0 8 P08559 1 |
| Transsulfuration and onecarbon metabolism 0.3167484258272196 0.2547946152625996 0.798881734445265 1.0 1.0 19 O43865,P48507,Q9Y617,P48637,P13995,O43175 6 |
| Ptf1a related regulatory pathway 0.690627843494089 0.2488599210544254 0.80346913845871 1.0 1.0 2 P35222 1 |
| Arrhythmogenic right ventricular cardiomyopathy 0.3363794610339937 0.2429896576398136 0.8080134093959177 1.0 1.0 15 Q99959,O43707,P50402,P02545,P35222 5 |
| Estrogen receptor pathway 0.5459965941845986 0.2360509648901911 0.8133931231048117 1.0 1.0 3 Q15067 1 |
| Ebola virus infection in host 0.2516116808407964 0.2313587121406475 0.8170361379821502 1.0 1.0 37 O75369,Q9UN37,O43707,P52294,P42566,P21333,O75569,P05556,P13747,P11387,P41440,P09496 12 |
| Insulin signaling in adipocytes diabetic condition 0.4037139521326494 0.2226096595247998 0.8238393178737473 1.0 1.0 4 P62753 1 |
| Insulin signaling in adipocytes normal condition 0.4037139521326494 0.2226096595247998 0.8238393178737473 1.0 1.0 4 P62753 1 |
| Mapk cascade 0.345078600043645 0.2147588943119877 0.8299553026687605 1.0 1.0 6 Q02750,P27361 2 |
| Fatty acid biosynthesis 0.3202531089831283 0.2146448629776021 0.830044213455619 1.0 1.0 17 P40939,O60488 2 |
| Pdgf pathway 0.3340852066060373 0.1942023967606311 0.8460174062552475 1.0 1.0 12 P63000,P19174,Q02750,P27361 4 |
| Pathogenic escherichia coli infection 0.2899531274163062 0.1898608368926961 0.849418181844583 1.0 1.0 21 P63104,Q92747,Q14247,O75116,P35222,O15144,P27348 7 |
| Wnt signaling 0.3227983574563181 0.1869321362722368 0.8517138421915167 1.0 1.0 15 P67870,P56545,O75116,Q08209 4 |
| Tgfbeta signaling in thyroid cells for epithelialmesenchymal transition 0.3888806216175779 0.1852054246297383 0.853067914459742 1.0 1.0 4 P27361,P08670 2 |
| Nrf2are regulation 0.3352991957655804 0.1832716576610547 0.854584871641999 1.0 1.0 9 P49841,Q96HS1 2 |
| Map3k1 role in promoting and blocking gonadal determination 0.3479833262964044 0.1711750985320855 0.8640860869891083 1.0 1.0 5 P49841 1 |
| Hypothesized pathways in pathogenesis of cardiovascular disease 0.3804539448872853 0.1655351427627403 0.8685227914370099 1.0 1.0 4 P21333,P27361 2 |
| Liver x receptor pathway 0.6357294510160734 0.1550170867361105 0.8768078468700258 1.0 1.0 2 O00767 1 |
| 7oxoc and 7betahc pathways 0.3241847966231451 0.1505720505777511 0.8803133103887841 1.0 1.0 10 Q9UBM7 1 |
| Gastric cancer network 2 0.3128385510527708 0.149062410018421 0.8815043869072985 1.0 1.0 15 P04637,Q8TDN6,Q86UE4,P35222,Q9HB71,Q14739 6 |
| Atm signaling in development and disease 0.2663326307584285 0.1470153122590461 0.8831199342114704 1.0 1.0 23 Q14739,Q14676,O43683 3 |
| Folate metabolism 0.3113661610652827 0.1437084453069857 0.88573070203783 1.0 1.0 15 P41440 1 |
| Neovascularisation processes 0.6263269639065838 0.1418602586737391 0.8871903857583652 1.0 1.0 2 P27361 1 |
| Apoptosisrelated network due to altered notch3 in ovarian cancer 0.3121019982446789 0.1268634051102433 0.8990485110499924 1.0 1.0 13 Q8NC51,P05067,Q9NRZ9 3 |
| Cori cycle 0.3151490593708866 0.1261154480935257 0.899640539297387 1.0 1.0 11 P04406,P04075 2 |
| Glial cell differentiation 0.6111616621170755 0.1224181977984323 0.902567827144256 1.0 1.0 2 P09543 1 |
| Base excision repair 0.2738738704498366 0.1137792185037019 0.9094128128282596 1.0 1.0 21 Q9NRF9,P18887,P09429 3 |
| Glutathione metabolism 0.30850777080823 0.1128614527530981 0.9101403972587006 1.0 1.0 6 P48637 1 |
| Mecp2 and associated rett syndrome 0.2794606985104326 0.1111359666488306 0.9115085281285652 1.0 1.0 20 Q9UQE7,P62753,Q96ST3,P35637,Q05086,O75475 6 |
| Energy metabolism 0.3022722779621859 0.1030782842282558 0.9179008398791704 1.0 1.0 14 Q08209,Q00059 2 |
| Zinc homeostasis 0.592053381862303 0.1009743593876745 0.9195708143706468 1.0 1.0 2 Q15043 1 |
| Genes controlling nephrogenesis 0.2982963437507615 0.0821414876078646 0.9345342022338754 1.0 1.0 8 P35222,Q13418 2 |
| Epo receptor signaling 0.2960636453905062 0.0804227396039433 0.9359010418906536 1.0 1.0 7 Q02750 1 |
| Il2 signaling pathway 0.2916970988413618 0.0635822909823458 0.949302832955341 1.0 1.0 10 P62753,Q02750 2 |
| Mthfr deficiency 0.284279306548003 0.0525312464399277 0.9581053986392172 1.0 1.0 8 P35790 1 |
| Thermogenesis 0.2300324666920919 0.0523262309198452 0.9582687526912024 1.0 1.0 28 Q96GM5,O43772,O14497,O60488 4 |
| Photodynamic therapyinduced ap1 survival signaling 0.2775584573337348 0.0490563450078892 0.9608743931295594 1.0 1.0 6 P04637,Q16539,P49327,P06400,P07900 5 |
| Embryonic stem cell pluripotency pathways 0.2845306075283261 0.0469992316718892 0.962513839890579 1.0 1.0 11 P49841,Q02750 2 |
| Micrornas in cardiomyocyte hypertrophy 0.2624859283415918 0.0466952360733966 0.9627561272686984 1.0 1.0 20 Q02750,P49841,O75116,Q08209,Q13144 5 |
| Glycogen synthesis and degradation 0.2766416050371689 0.0428905753259255 0.9657887616388944 1.0 1.0 16 P49841,P49840 2 |
| Leptininsulin signaling overlap 0.5016681831968544 0.0396024255900522 0.9684100936165072 1.0 1.0 2 O14654 1 |
| Ciliary landscape 0.2740704231418562 0.0337057272516628 0.9731118118827258 1.0 1.0 112 P63167,P33992,Q96FJ2,P35222,Q9Y4W6,P07197,O15173,Q96PK6,P56545,P17844,P43034,Q9Y266,P84243,O95292,P30084,P27105,P08670,P09669,Q8IYI6,O60343,Q9NVJ2,P60660 22 |
| Familial hyperlipidemia type 4 0.4707309675462573 0.0301879606279334 0.975917150183944 1.0 1.0 2 P49327 1 |
| Bladder cancer 0.2645061084251344 0.0283515437895627 0.9773817711025284 1.0 1.0 6 P04637,Q02750 2 |
| Robo4 and vegf signaling pathways crosstalk 0.4355474673946015 0.0239231617685589 0.9809138991487654 1.0 1.0 2 P63000 1 |
| Foxa2 pathway 0.3746966019417473 0.0228697591506762 0.98175416278578 1.0 1.0 3 P49327,Q13085 2 |
| Deregulation of rab and rab effector genes in bladder cancer 0.3145283591143393 0.0186365835554629 0.9851310184413122 1.0 1.0 2 Q8IWJ2 1 |
| Fas ligand pathway and stress induction of heat shock proteins 0.2666237790841013 0.0130880321000535 0.9895575593826608 1.0 1.0 15 P20700,Q9UER7,P09874,P02545 4 |
| Angiotensin ii receptor type 1 pathway 0.3285800970873653 0.0104209426266027 0.9916854412575264 1.0 1.0 3 P28482,P63244 2 |
| Mirna regulation of dna damage response 0.2284604865107666 0.0093706265098919 0.9925234312007584 1.0 1.0 24 P15927,P41440 2 |
| Nonhomologous end joining 0.3216019417475665 0.0093590038769865 0.9925327043134756 1.0 1.0 3 P78527,P13010 2 |
|
|
